Literature DB >> 11181367

Eagle-type methicillin resistance: new phenotype of high methicillin resistance under mec regulator gene control.

N Kondo1, K Kuwahara-Arai, H Kuroda-Murakami, E Tateda-Suzuki, K Hiramatsu.   

Abstract

We report a novel phenotype of methicillin resistance, designated "Eagle-type" resistance, which is characteristic in its resistance to high concentrations of methicillin (64 to 512 microg/ml) and susceptibility to low concentrations of methicillin (2 to 16 microg/ml). The type of resistance was expressed in mutant strains selected with high concentrations (e.g., 128 to 512 microg/ml) of methicillin from the pre-methicillin-resistant Staphylococcus aureus strain N315, whose mecA gene transcription is strongly repressed by the mecI gene-encoded repressor protein MecI. The Eagle-type mutant strains harbored no mutation in the mecI gene or in the operator region of mecA gene to which MecI repressor is supposed to bind. In the representative Eagle-type strain h4, repression of mecA gene transcription and penicillin-binding protein 2' production were found to be released by exposing the cells to a high concentration (128 microg/ml) of methicillin but not to lower concentrations (1 and 8 microg/ml) of methicillin. The strain h4 expressed paradoxical susceptibility (Eagle effect) to the cytokilling activity of methicillin. Experimental deletion of mecI gene from the chromosome of h4 by mecI-specific gene substitution converted its Eagle-type resistance to homogeneously high methicillin resistance. We cloned two novel genes, designated hmrA and hmrB, from genomic library of h4, which conferred Eagle-type resistance to N315 when introduced into the cell in multiple copies. The genes were shown to confer homogeneous methicillin resistance to the heterogeneously methicillin-resistant strain LR5 when they were introduced into on multicopy plasmids. This result strongly indicated that the genetic alteration responsible for the expression of the Eagle phenotype is identical, or equivalent in its effect, to the genetic alteration underlying heterogeneous-to-homogeneous conversion of methicillin resistance in S. aureus.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11181367      PMCID: PMC90380          DOI: 10.1128/AAC.45.3.815-824.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  31 in total

1.  Molecular cloning and nucleotide sequence determination of the regulator region of mecA gene in methicillin-resistant Staphylococcus aureus (MRSA).

Authors:  K Hiramatsu; K Asada; E Suzuki; K Okonogi; T Yokota
Journal:  FEBS Lett       Date:  1992-02-24       Impact factor: 4.124

2.  Biosynthesis of lipid A in Escherichia coli. Acyl carrier protein-dependent incorporation of laurate and myristate.

Authors:  K A Brozek; C R Raetz
Journal:  J Biol Chem       Date:  1990-09-15       Impact factor: 5.157

3.  Purification and characterization of a thermostable carboxypeptidase from the extreme thermophilic archaebacterium Sulfolobus solfataricus.

Authors:  S Colombo; S D'Auria; P Fusi; L Zecca; C A Raia; P Tortora
Journal:  Eur J Biochem       Date:  1992-06-01

4.  Evolution and resistance expression of MRSA. Evaluation of beta-lactam antibiotics against a set of isogenic strains with different types of phenotypic expression.

Authors:  K Asada; Y Inaba; E Tateda-Suzuki; K Kuwahara-Arai; T Ito; K Hiramatsu
Journal:  Acta Biochim Pol       Date:  1995       Impact factor: 2.149

Review 5.  Genetics and regulation of bacterial lipid metabolism.

Authors:  T Vanden Boom; J E Cronan
Journal:  Annu Rev Microbiol       Date:  1989       Impact factor: 15.500

6.  Direct quantitative transcript analysis of the agr regulon of Staphylococcus aureus during human infection in comparison to the expression profile in vitro.

Authors:  C Goerke; S Campana; M G Bayer; G Döring; K Botzenhart; C Wolz
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

7.  The function of acyl carrier protein in the synthesis of membrane-derived oligosaccharides does not require its phosphopantetheine prosthetic group.

Authors:  H Therisod; E P Kennedy
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

8.  The rate of bactericidal action of penicillin in vitro as a function of its concentration, and its paradoxically reduced activity at high concentrations against certain organisms.

Authors:  H EAGLE; A D MUSSELMAN
Journal:  J Exp Med       Date:  1948-07       Impact factor: 14.307

9.  Regulation of phospholipid synthesis in Escherichia coli. Composition of the acyl-acyl carrier protein pool in vivo.

Authors:  C O Rock; S Jackowski
Journal:  J Biol Chem       Date:  1982-09-25       Impact factor: 5.157

10.  Immobilization and purification of enzymes with staphylococcal protein A gene fusion vectors.

Authors:  B Nilsson; L Abrahmsén; M Uhlén
Journal:  EMBO J       Date:  1985-04       Impact factor: 11.598

View more
  25 in total

1.  Fitness cost of SCCmec and methicillin resistance levels in Staphylococcus aureus.

Authors:  Miriam Ender; Nadine McCallum; Rajan Adhikari; Brigitte Berger-Bächi
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

2.  Cefoxitin does not induce production of penicillin binding protein 2a in methicillin-susceptible Staphylococcus aureus strains.

Authors:  Ana Lúcia da Costa Darini; Izabel Cristina Vanzato Palazzo
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

3.  Inducibly cefoxitin-resistant Macrococcus-like organism falsely identified as methicillin-resistant Staphylococcus aureus on CHROMagar with oxacillin.

Authors:  Joseph E Rubin; Manuel Chirino-Trejo
Journal:  J Clin Microbiol       Date:  2010-06-16       Impact factor: 5.948

4.  Differential expression of methicillin resistance by different biofilm-negative Staphylococcus epidermidis transposon mutant classes.

Authors:  Dietrich Mack; Axel Sabottke; Sabine Dobinsky; Holger Rohde; Matthias A Horstkotte; Johannes K-M Knobloch
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

5.  Compensation of fitness costs and reversibility of antibiotic resistance mutations.

Authors:  Pia Schulz zur Wiesch; Jan Engelstädter; Sebastian Bonhoeffer
Journal:  Antimicrob Agents Chemother       Date:  2010-02-22       Impact factor: 5.191

Review 6.  Antimicrobial heteroresistance: an emerging field in need of clarity.

Authors:  Omar M El-Halfawy; Miguel A Valvano
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

7.  Complete genome sequence of Macrococcus caseolyticus strain JCSCS5402, [corrected] reflecting the ancestral genome of the human-pathogenic staphylococci.

Authors:  Tadashi Baba; Kyoko Kuwahara-Arai; Ikuo Uchiyama; Fumihiko Takeuchi; Teruyo Ito; Keiichi Hiramatsu
Journal:  J Bacteriol       Date:  2008-12-12       Impact factor: 3.490

8.  Paradoxical effect of caspofungin: reduced activity against Candida albicans at high drug concentrations.

Authors:  David A Stevens; Marife Espiritu; Rachana Parmar
Journal:  Antimicrob Agents Chemother       Date:  2004-09       Impact factor: 5.191

9.  Genetic changes associated with glycopeptide resistance in Staphylococcus aureus: predominance of amino acid substitutions in YvqF/VraSR.

Authors:  Yoshihisa Kato; Takahisa Suzuki; Takashi Ida; Kazunori Maebashi
Journal:  J Antimicrob Chemother       Date:  2010-01       Impact factor: 5.790

10.  In vitro activities of ME1036 (CP5609), a novel parenteral carbapenem, against methicillin-resistant staphylococci.

Authors:  Mizuyo Kurazono; Takashi Ida; Keiko Yamada; Yoko Hirai; Takahisa Maruyama; Eiki Shitara; Minoru Yonezawa
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.